DSM NUTRITIONAL PRODUCTS (UK) LIMITED

• ◆

  1 PSC ceased in last 24 months

  Significant control changed hands — see the Ownership section.

1. DSM NUTRITIONAL PRODUCTS (UK) LIMITED 2004-03-31 → present
2. ROCHE VITAMINS (UK) LIMITED 2000-12-14 → 2004-03-31
3. ROCHE VITAMINS LIMITED 2000-09-13 → 2000-12-14
4. SEVCO 1174 LIMITED 2000-07-11 → 2000-09-13

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 101

Reporting scope

Consolidated group

Auditor

Azets Audit Services Limited

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The financial statements have been prepared on a going concern basis. The company's business activities, a review of the business and a description of the principal risks and uncertainties together with the company's financial risk management processes and narrative regarding its exposure to key financial risks are outlined in the Strategic Report. ... Consequently, the Directors are confident that the company will have sufficient funds to continue to meet its liabilities as they fall due for at least 12 months from the date of approval of the financial statements and therefore have prepared the financial statements on a going concern basis.”

Significant events

• “During 2024 the company maintained its focus on continuous improvement and sustainability of its existing operations. In November 2021, the company announced plans for a large-scale production site for its novel methane reducing feed additive for ruminants, Bovaer® with a new plant planned for the company's Dalry site. The company commenced design work for the new facility in 2021 and construction work began early in 2023. Construction will continue through 2025 and 2026 with the first products from the new plant expected to be produced towards the end of 2026.”
• “On 20th September 2023, the company advised employees at the Dalry site that a reorganisation was being proposed to improve the cost competitiveness of the Dalry site. Following consultation, eleven employees were made redundant with ten leaving in 2024 and the remaining one in 2025.”
• “On 15th February 2024, dsm-firmenich AG announced the initiation of a process to carve out and separate the Animal Nutrition and Health ("ANH") business unit from the group. dsm-firmenich AG believes that the full potential of the ANH business could be best realised through a different ownership structure. Within the company, the Heanor site and operations are part of the ANH business unit and were included in this carve out activity with the asset transfer to a new legal entity taking place on 1 July 2025.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

7

last 12 months

Capital events

1

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  -11.2%

  £273,323,000 → £242,841,000

• Cash

  —

  Not reported

• Net assets

  +86.1%

  £187,401,000 → £348,744,000

• Employees

  +0.9%

  470 → 474

• Operating profit

  +48%

  £7,853,000 → £11,621,000

• Profit before tax

  +52.8%

  £7,877,000 → £12,036,000

• Wages

  +12.5%

  £22,780,000 → £25,620,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers